Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | AR | P10275 | 14/20 | 0.50 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.48 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.48 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12147466 | 0.91 | ALDH1A1 (0.53) | ALDH1A1KDM4EUSP2ARIMPDH2 | |
| SCHEMBL12147725 | 0.88 | ALDH1A1 (0.52) | ALDH1A1KDM4EUSP2ARIMPDH2 | |
| SCHEMBL2761994 | 0.87 | ALDH1A1 (0.59) | ALDH1A1KDM4EUSP2ARIMPDH2 | |
| SCHEMBL10822944 | 0.87 | AR (0.57) | ALDH1A1KDM4EUSP2ARIMPDH2 | |
| SCHEMBL19313480 | 0.87 | AR (0.53) | ALDH1A1KDM4EUSP2AR | |
| SCHEMBL5695734 | 0.85 | AR (0.47) | ALDH1A1KDM4EUSP2ARIMPDH2 | |
| SCHEMBL15298755 | 0.85 | AR (0.59) | ALDH1A1KDM4EUSP2ARIMPDH2 | |
| SCHEMBL24101484 | 0.84 | ESR1 (0.49) | ALDH1A1KDM4EUSP2ARIMPDH2 | |
| SCHEMBL1343373 | 0.83 | ALDH1A1 (0.55) | ALDH1A1KDM4EUSP2ARIMPDH2 | |
| SCHEMBL5695670 | 0.79 | KDM4E (0.55) | ALDH1A1KDM4ESTING1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912646-B2 | Transmembrane pores formed by aromatic oligoamide foldamers and uses of same | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2024-02-27 | — | — | US | disclosed |
| US-20230287262-A1 | PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| US-20230287262-A1 | PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| US-20220380301-A9 | TRANSMEMBRANE PORES FORMED BY AROMATIC OLIGOAMIDE FOLDAMERS AND USES OF SAME | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 2022-12-01 | — | — | US | disclosed |
| US-20210355078-A1 | TRANSMEMBRANE PORES FORMED BY AROMATIC OLIGOAMIDE FOLDAMERS AND USES OF SAME | UNIV NEW YORK STATE RES FOUND (US) | 2021-11-18 | — | — | US | disclosed |
| US-11072578-B2 | Transmembrane pores formed by aromatic oligoamide foldamers and uses of same | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2021-07-27 | — | — | US | disclosed |
| US-20200199066-A1 | TRANSMEMBRANE PORES FORMED BY AROMATIC OLIGOAMIDE FOLDAMERS AND USES OF SAME | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210355078-A1 | TRANSMEMBRANE PORES FORMED BY AROMATIC OLIGOAMIDE FOLDAMERS AND USES OF SAME | AQP1, STOM, SLC22A8 | ALDH1A1 4354/4885KDM4E 4558/4885USP2 2848/4885 |
| US-11912646-B2 | Transmembrane pores formed by aromatic oligoamide foldamers and uses of same | AQP1, STOM, SLC22A8 | ALDH1A1 4354/4885KDM4E 4558/4885USP2 2848/4885 |
| US-11072578-B2 | Transmembrane pores formed by aromatic oligoamide foldamers and uses of same | AQP1, STOM, SLC22A8 | ALDH1A1 4354/4885KDM4E 4558/4885USP2 2848/4885 |
| US-20200199066-A1 | TRANSMEMBRANE PORES FORMED BY AROMATIC OLIGOAMIDE FOLDAMERS AND USES OF SAME | AQP1, STOM, SLC22A8 | ALDH1A1 4354/4885KDM4E 4558/4885USP2 2848/4885 |
| US-20220380301-A9 | TRANSMEMBRANE PORES FORMED BY AROMATIC OLIGOAMIDE FOLDAMERS AND USES OF SAME | AQP1, STOM, SLC22A8 | ALDH1A1 4354/4885KDM4E 4558/4885USP2 2848/4885 |
| US-20230287262-A1 | PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND | NUDC, CCNL2, SPIN3 | ALDH1A1 2125/4885KDM4E 1663/4885USP2 872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.